 BOSTON, Sept. 30, 2021 PRNewswire -- Haemonetics Corporation NYSE: HAE, a global medical technology company focused on delivering innovative medical solutions to drive better patient outcomes, announced that the VASCADE MVP Venous Vascular Closure System is now the first and only vascular closure device to receive FDA indication for same-day discharge following atrial fibrillation AF ablation. 